Angelo Cefalo

Angelo Cefalo

Auto-generated profile, based on publicly available information

Angelo Cefalo

Department of Hygiene and Prevention, Federico II University of Naples, 80138 Napoli, Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
MBMario Giosue' Balzanelli
Mario Giosue' Balzanelli
PDPietro Distratis
Pietro Distratis
Gianna DipalmaGianna Dipalma
Gianna Dipalma
Luigi VimercatiLuigi Vimercati
Luigi Vimercati
OCOrazio Catucci
Orazio Catucci
Ciro Gargiulo IsaccoCiro Gargiulo Isacco
Ciro Gargiulo Isacco
Background: A novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) emerged in December 2019 in China, spreading worldwide. The aim of the present investigation was to evaluate the immunological response and the clinical subset of peripheral lymphocyte subset alteration in COVID-19 infection. Methods: the study was conducted on four different clinical groups (n = 4; total n = 138). Each individual was assigned to different groups based on specific criteria evaluated at the admission such as fever, dyspnea, arterial blood gas analysis (ABG), oral-nasopharyngeal swab/RT-PCR, and thoracic CT-scan. Treatment was performed only after blood samples were collected from each patient (PP and PP) at day 1. The blood samples were analyzed and tested the same day (CBC and Flowcytometry). The positive–positive group (PP n = 45; F = 18/ M = 27; median age = 62.33), comprised individuals affected by COVID-19 who showed fever, dyspnea (ABG = pO2 < 60), confirmed positive by oral-nasopharyngeal swab/RT-PCR and with CT-scan showing ground-glass opacities. The negative–positive (NP; n = 37; F = 11/M = 26; median age = 75.94) or “COVID-like” group comprised individuals with fever and dyspnea (ABG = pO2 < 60), who tested negative to nasopharyngeal swab/RT-PCR, with CT-scans showing ground-glass opacities in the lungs. The negative–affected group (NA; n = 40; F = 14/M = 26; median age = 58.5) included individuals negative to COVID-19 (RT-PCR) but affected by different chronic respiratory diseases (the CT-scans didn’t show ground-glass opacities). Finally, the negative–negative group (NN; n = 16; F = 14/M = 2) included healthy patients (NN; n = 16; median age = 42.62). Data and findings were collected and compared. Results: Lymphocytes (%) cells showed a decline in COVID-19 patients. The subsets showed a significant association with the inflammatory status in COVID-19, especially with regard to increased neutrophils, T-killer, T-active, T-suppressor, and T-CD8+CD38+ in individuals belong to the either COVID-19 and Covid-like NP group. Conclusions: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and progression of COVID-19. The level of sub-set cells T-lymphocytes (either high or low) and B-lymphocytes could be used as an independent predictor for COVID-19 severity and treatment efficacy.

14 February 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MBMario Giosue' Balzanelli
Mario Giosue' Balzanelli
PDPietro Distratis
Pietro Distratis
OCOrazio Catucci
Orazio Catucci
ACAngelo Cefalo
Angelo Cefalo
RLRita Lazzaro
Rita Lazzaro
Ciro Gargiulo IsaccoCiro Gargiulo Isacco
Ciro Gargiulo Isacco
Due to the promising effects of mesenchymal stem cells (MSCs) in the treatment of various diseases, this commentary aimed to focus on the auxiliary role of MSCs to reduce inflammatory processes of acute respiratory infections caused by the 2019 novel coronavirus (COVID-19). Since early in 2020, COVID-19, a consequence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly affected millions of people world-wide. The SARS-CoV-2 infection in children appears to be an unusual event. Despite the high number of affected adult and elderly, children and adolescents remained low in amounts, and marginally touched. Based on the promising role of cell therapy and regenerative medicine approaches in the treatment of several life-threatening diseases, it seems that applying MSCs cell-based approaches can also be a hopeful strategy for improving subjects with severe acute respiratory infections caused by COVID-19.

7 September 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
MBMario Giosue' Balzanelli
Mario Giosue' Balzanelli
PDPietro Distratis
Pietro Distratis
RLRita Lazzaro
Rita Lazzaro
ACAngelo Cefalo
Angelo Cefalo
OCOrazio Catucci
Orazio Catucci
Ciro Gargiulo IsaccoCiro Gargiulo Isacco
Ciro Gargiulo Isacco
Background: Based on recent findings, we speculated the existence of the lung, heart, and kidney axis as the main pathway for the COVID-19 disease progression. Methods: This paper reports on an observational study conducted by a team of researchers and doctors of the 118-Pre-Hospital and Emergency Department of SG Moscati of Taranto City in Italy. The study was conducted on a totality of 185 participants that were divided into three groups. The study group included COVID-19 affected patients (PP n = 80), the first control group included patients with different pathologies (non-COVID-19 NNp n = 62) of the SG Moscati Hospital, and the second control group included healthy individuals (NNh n = 43). The core of the current trial was focused on assessing the level of the vitamin D (serum 25(OH) D concentration), IL-6, and the renal glomerular filtrate (eGFR) in COVID-19 disease and non-COVID-19 patients in both groups. Results: It was observed that the majority of COVID-19-infected patients showed a progressive multi-organ involvement, especially in regard to the lung, kidney, and heart. The majority of the COVID-19 patients exhibited preexisting comorbidities which include cardiovascular, respiratory, and renal disorders accompanied by a severely low level of vitamin D, extremely high level of IL-6, and low glomerular filtration rate (eGFR). The significant overall damages exerted by the immune-mediated responses under the hyper-expression of proinflammatory cytokines and interleukins, such as IL-6, may be facilitated by either a decreased level of vitamin D or the ageing process. The reduced presence of vitamin D was often found together with a reduced functionality of renal activity, as revealed by the low eGFR, and both were seen to be concomitant with an increased mortality risk in patients with lung disorders and heart failure (HF), whether it is showed at baseline or it develops during manifestation of COVID-19. Therefore, the documentation of the modifiable risk factors related to SARS-CoV-2 and lung impairment in older patients with kidney and heart disease may help the clinician to better manage the situation. Conclusions: This paper addresses how a low level of vitamin D and older age may be indicative of systemic worsening in patients with COVID-19, with a goal of providing a broader context in which to view a better therapeutic approach.

8 November 2024 in Electronics
Verified
Journal Article
Open access
PDF file
SASergey K. Aityan
Sergey K. Aityan
AMAbdolreza Mosaddegh
Abdolreza Mosaddegh
Rolando HerreroRolando Herrero
Rolando Herrero
Francesco InchingoloFrancesco Inchingolo
Francesco Inchingolo
KNKieu C D Nguyen
Kieu C D Nguyen
Ciro Gargiulo IsaccoCiro Gargiulo Isacco
Ciro Gargiulo Isacco
The application of AI (Artificial Intelligence) in emergency medicine helps significantly improve the quality of diagnostics under limitations of resources and time constraints in emergency cases. We have designed a comprehensive AI-based diagnostic and treatment plan decision-support system for emergency medicine by integrating the available LLMs (Large Language Models), like ChatGPT, Gemini, Claude, and others, and tuning them up with additional training on actual emergency cases. There is a special focus on early detection of life-threatening and time-sensitive diseases like sepsis, stroke, and heart attack, which are the major causes of death in emergency medicine. Additional training was conducted on a total of 600 cases (300 sepsis; 300 non-sepsis). The collective capability of the integrated LLMs is much stronger than each individual engine. Emergency cases can be predicted based on information from multiple sensors and streaming sources combining traditional IT (Information Technology) infrastructure with Internet of Things (IoT) schemes. Medical personnel compare and validate the AI models used in this work.